FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Lumigan | Allergan | Latisse

FDA reviewer confirms drug's alluring side effect

Tools

An FDA reviewer is agreeing with Allergan that its glaucoma drug Lumigan also has an alluring side effect: it lengthens and thickens eyelashes. Allergan is seeking the agency's approval to sell the drug as Latisse to enhance upper eyelashes. And, as the Wall Street Journal notes, an approval would be a first for eyelash care. Report

More stories about Lumigan   Allergan   Latisse  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.